India likely to get Dengue vaccination by 2019 end

New Delhi : India is likely to get its vaccination against popular disease Dengue by the end of 2019. Drug maker Panacea Biotec has reportedly secured permissions to conduct a clinical trial in the country.

The clinical trials on humans will begin by early 2018, a spokesperson from Panacea Biotec told Hindustan Times.

This year, at least 216 people have lost their lives in India. The vaccine will help in decreasing death cases and will also cut down the cost of treatment.

“As dengue is a big challenge for India and a vaccine direly required, we have given a go-ahead for trials for the vaccine by TDB and Panacea Biotec,” said GN Singh, DCGI.

“We are facilitating the trials in a speedy manner. As a regulator, we are ensuring that the vaccine is effective and safe for the people.”

Panacea Biotec, in collaboration with National Institutes of Health (NIH), US, has developed the advanced dengue vaccine with proven safety in pre-clinical studies.

A single dose of vaccine can build a strong immune system inside the human body to fight against the disease.